JP. Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension.
AN ABUNDANCE OF EPIDEMIOLOGIC and clinical observations attests to the frequent occurrence of renal artery disease and attendant renal artery stenosis (RAS) and to the pathological significance and complication of such lesions. For example, hemodynamically significant atherosclerotic renal vascular disease occurs in up to 7% of the population over 65 yr of age, and atherosclerotic RAS is demonstrable in up to 20 and 50% of patients undergoing angiography for coronary artery disease and peripheral vascular disease, respectively (10, 33) . The pathophysiological consequences of RAS are substantial and many; in addition to inducing renovascular hypertension (RVH) and hyperaldosteronism and predisposing to cardiovascular diseases, RAS can cause ischemic nephropathy and is increasingly incriminated in the pathogenesis of chronic kidney disease and end-stage kidney disease. For example, up to 40% of elderly hypertensive patients with newly documented endstage renal disease and no demonstrable primary renal disease have significant RAS (34) . The management of patients with renal artery disease and attendant stenosis is a subject of considerable controversy, in part because the pathobiological alterations induced in the kidney as a consequence of such stenosis are poorly understood.
The Goldblatt two-kidney, one-clip (2K1C) rat hypertension model is a long-established and widely employed model in the study of RAS and RVH (6, 14, 24, 35) . In addition to providing a reproducible and clinically relevant model of systemic hypertension, the 2K1C model exhibits a prominent divergence of biological responses in the two kidneys: the stenotic kidney displays progressive atrophy, whereas the contralateral kidney exhibits a compensatory growth response. These two facets of this model, atrophy of one kidney and increased growth of the other, are of special relevance to chronic kidney disease for at least two reasons: first, a characteristic histological feature in chronic kidney disease is structural heterogeneity wherein a certain subset of nephrons exhibit injury and atrophy, whereas other nephrons display structural enlargement and hyperfunction; second, elucidating the nature of progressive kidney disease requires an understanding not only of the process of atrophy but also of compensatory growth, since the latter may serve as a precursor to chronic injury, nephron atrophy, and, ultimately, progressive kidney disease (29, 30) . The 2K1C model thus provides an experimental model that affords the analysis of these contrasting biological responses, an analysis that may be particularly relevant to chronic progressive kidney disease. However, unlike the use of the 2K1C model in the study of the pathogenesis of systemic hypertension, the current literature is relatively deficient in studies that examine the basis for atrophy of the stenotic kidney, on one hand, and the basis for compensatory enlargement of the contralateral kidney, on the other; indeed, even the rudimentary question whether enlargement of the contralateral kidney reflects hypertrophy or hyperplasia has not been addressed. With the use of the murine model of 2K1C, the present study addresses these issues by undertaking a detailed, temporal analysis of candidate genes and proteins that are considered critical participants in biological processes relevant to injury, atrophy, and growth in chronic kidney disease.
MATERIALS AND METHODS
Animals. Studies were conducted on 43 male C57BL/6 mice (NCI-Frederick, Frederick, MD), 6 -8 wk of age, weighing 20 -25 g. All animal procedures were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and the study protocol was approved by the Mayo Clinic College of Medicine Institutional Animal Care and Use Committee.
Surgical procedures. The development of RVH in mice critically depends on the extent of RAS. Weisel et al. (39) have shown that a clip size of 0.1 mm and smaller causes renal infarction, whereas a clip size of 0.13 mm and larger does not produce significant hypertension or renal atrophy. We therefore employed a clip size of 0.12 mm for these studies. Mice were anesthetized with a ketamine-xylazine mixed cocktail (100 mg/kg ip ketamine, 10 mg/kg ip xylazine). The skin of the back was shaved and wiped clean with topical antiseptic and alcohol. The left kidney was exposed through a small flank incision ϳ2 cm in length and externalized. The renal artery was isolated, and a small segment was dissected free of the renal vein. In 23 animals, a sterilized silver U-shaped clip (internal diameter 0.12 mm) was placed around the main renal artery, with the open end away from the renal vein. As controls, 20 sham-operated animals underwent flank incision and left renal artery isolation, but no silver clip was placed. The mice were returned to routine housing with access to standard chow and water ad libitum following recovery from anesthesia. Weekly blood pressure measurements were obtained by the tail-cuff method using the XBP1000 noninvasive blood pressure system (Kent Scientific, Torrington, CT). Animals were euthanized after 2, 5, and 11 wk. Mice were weighed and anesthetized with ketamine-xylazine, and the clipped and contralateral kidneys were excised. The kidneys were weighed, and portions were either fixed for histopathological analysis and immunohistochemical staining or snap frozen in liquid nitrogen for Western and Northern blot analyses.
Histology and immunohistochemistry. Renal tissue was fixed in 10% neutral buffered formalin, dehydrated, and embedded in paraffin per standard techniques. Sections were cut at a thickness of 4 m and stained with hematoxylin-eosin (H&E), Masson's trichrome, and Sirius red. Immunostains were performed for ␣-smooth muscle actin (␣-SMA; DakoCytomation, Carpinteria, CA) and Ki-67 (Vector Laboratories, Burlingame, CA). Antigen retrieval was carried out by heat treatment in EDTA or citrate buffer for 30 min using a vegetable steamer. Avidin/Biotin Block (Vector Labs) was used to block endogenous biotin in the kidney. Commercially available kits [Mouse On Mouse (MOM) kit and rabbit VectaStain ABC kit (Vector Labs) and Envision Plus-HRP kit (DakoCytomation)] were used for the blocking, secondary antibody, and amplification steps. NovaRed (Vector Labs) was used for color development, followed by hematoxylin counterstain. To facilitate consistency between staining batches, we stained the slides on the DakoAutostainer, an automated staining machine.
Assessment of histopathological features. Glomerular, interstitial, tubular, and vascular features of renal tissue were analyzed on H&E-and trichrome-stained slides. Quantitative analyses of histopathological manifestations of renal injury were performed, in a blinded fashion, using the MetaVue image analysis system (Universal Imaging, Downington, PA). The extent of interstitial fibrillar collagen deposition was assessed in Sirius red-stained slides observed under polarized light and quantitated as the amount of positively birefringent material relative to the entire cortical surface area.
Western blot analysis and immunoprecipitation. Tissues were homogenized in 1ϫ lysis buffer (Cell Signaling) with protease inhibitors (protease inhibitor cocktail; Roche Applied Science, Indianapolis, IN) and phosphatase inhibitors (phosphatase inhibitor cocktail 2; Sigma, St. Louis, MO). Homogenates were centrifuged at 10,000 g for 10 min at 4°C, and the resulting supernatants were used for Western blot analysis. Protein concentrations were determined using the Lowry method (22) . Equal amounts of lysate, denatured in loading buffer for 5 min at 100°C, were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in the Criterion system (BioRad Laboratories, Burlingame, CA) followed by transfer to polyvi- nylidene difluoride membranes (Bio-Rad). The membranes were blocked with 1ϫ casein (Vector Labs) in Tris-buffered saline (TBS) containing 0.5% Tween 20 and incubated with primary antibodies for proliferating cell nuclear antigen (PCNA) and phospho-extracellular signal-regulated kinase (p-ERK; Santa Cruz Biotechnology, Santa Cruz, CA), cyclin D1 (Cell Signaling), cyclin E and cyclin B1 (Abcam, Cambridge, MA), cyclin A (Santa Cruz Biotechnology), p27 and p21 (Biosource International, Camarillo, CA), p53 and Smad2/3 (BD Biosciences Pharmingen, San Diego, CA), and caspase-3 (Cell Signaling), followed by horseradish peroxidase (HRP)-conjugated secondary antibodies (SouthernBiotech, Birmingham, AL; and Stressgen). The blots were then visualized by exposure to X-ray film using the ECL Western blot detection reagents and analysis system (Amersham Biosciences, Piscataway, NJ). The blots were stripped and reprobed with ERK2 (Santa Cruz Biotechnology) antibody to normalize for gel loading and transfer efficiency. For immunoprecipitation, kidney lysates (200 g) were first precleared by incubation with magnetic protein G beads (New England BioLabs, Ipswich, MA) for 1 h. Supernatants were immunoprecipitated with 3 g of p21 antibody (Biosource International) for 1 h in 1ϫ lysis buffer and then incubated with 25 l of magnetic protein G beads at 4°C overnight. The immunoprecipitated samples were separated on SDS gels and probed with PCNA and cyclin B1 antibodies. Densitometric analyses were performed with the Kodak Image Station 440CF system (Eastman Kodak, Rochester, NY).
Measurement of protein to DNA ratio. Kidney lysates were prepared as described in Western blot analysis and immunoprecipitation. After brief sonication, 100 ml of lysate (0.1 mg/ml) were mixed with 1 g/ml compound H33342 (Calbiochem, San Diego, CA). Fluorescence was measured using an FL600 microplate fluorescence reader (Bio-Tek Instruments, Winooski, VT) at excitation of 360 nm and emission of 460 nm. Sonicated salmon sperm DNA (Stratagene, La Jolla, CA) was used to prepare the standard curve. The enhancement of fluorescence of 1 g/ml compound H33342 is linear in the presence of 0 -10 g DNA/ml. Protein concentrations were determined using the Lowry method.
Northern blot analysis. Kidney tissues were homogenized in Trizol (Invitrogen, Carlsbad, CA) and extracted with phenol-chloroform, and the RNA was precipitated with isopropanol. Total RNA (20 g/lane) was electrophoresed through a 1% agarose, 2.2 M formaldehyde denaturing gel and transferred to nylon membranes (Schleicher & Schuell, Keene, NH) as previously described (8, 9) . The monocyte chemoattractant protein-1 (MCP-1) cDNA probe was prepared as previously described (17) . The transforming growth factor (TGF)-␤1 cDNA probe was obtained from the American Type Culture Collection (ATCC 63197; Manassas, VA). Probes (25 ng) were labeled with [␣-32 P]dCTP using the random primer method. Membranes were hybridized at 65°C overnight in a 0.5 M sodium phosphate buffer, pH 7.0, containing 1 mM EDTA, 7% SDS, and 1% bovine serum albumin, as described by Church and Gilbert (4). Autoradiograms were quantitated by computer-assisted video densitometry. As a loading control, blots were reprobed for the housekeeping gene GAPDH, as previously described (8) .
Statistical analysis. Data are means Ϯ SE. Group or pairwise comparisons were evaluated using Student's t-test. P values Ͻ0.05 were considered statistically significant.
RESULTS

RAS mice develop hypertension within 1 wk of RAS.
Mean systolic blood pressure in animals subjected to unilateral RAS increased significantly in the first week after surgery from a baseline of 97 Ϯ 2 to 131 Ϯ 4 mmHg (P Ͻ 0.05) and was persistently elevated in this range throughout the 11-wk experiment (Fig. 1) . In sham-operated control mice, systolic blood pressure did not significantly differ from baseline over the experimental period. Heart-to-body weight ratios were significantly increased 5 wk after surgery in RAS mice, indicating that hypertension was associated with the development of myocardial hypertrophy (data not shown).
RAS mice develop renal atrophy in the stenotic kidney and hypertrophy/hyperplasia in the contralateral kidney. Mean kidney weight, body weight, and the ratio of kidney to body weight of mice euthanized 2, 5, and 11 wk after induction of RAS are shown in Table 1 . Two weeks following surgery, the RAS mice had developed compensatory enlargement of the contralateral kidney, whereas the size of the clipped kidney was maintained (Table 1) . At 5 and 11 wk, the contralateral kidney remained enlarged, but the weight of the stenotic kidney progressively declined, indicating the development of atrophy (Table 1) .
Histopathological alterations in the stenotic and contralateral kidneys of RAS mice. Both the stenotic and contralateral kidneys demonstrated minimal histopathological alterations 2 wk after surgery. At 5 and 11 wk, the stenotic kidneys showed interstitium. Small and medium-sized arteries showed variable degrees of medial hypertrophy and intimal sclerosis. The contralateral kidneys showed minimal glomerulosclerosis, interstitial fibrosis, tubular atrophy, or interstitial inflammation at all time points (Fig. 2) .
Proliferative activity is markedly and persistently increased in the stenotic kidney and transiently increased in the contralateral kidney in the RAS model. We sought to determine the extent to which cell proliferation contributed to the development of compensatory enlargement of the contralateral kidney of RAS mice. Based on Western blot analysis, expression of the proliferation marker PCNA in the contralateral kidney was increased in the early time points (2 and 5 wk) but by 11 wk had reduced to levels not statistically different from the contralateral kidney of sham-operated controls (Fig. 3A) . On the other hand, PCNA in the stenotic kidney was significantly increased throughout the experimental period (2 to 11 wk) (Fig. 3A) . Immunohistochemical analysis for the Ki-67 antigen was performed to identify the cell type(s) expressing this marker of proliferation. In all cases, expression of Ki-67 was identified primarily within cortical tubular epithelial cells, with staining of isolated cells within medullary tubules, glomeruli, and interstitial inflammatory cells. Quantitative analysis (number of positive cells/ϫ200 field, measured over the renal cortex) showed that the pattern of Ki-67 expression paralleled that of PCNA, as assessed by Western blot analysis. Expression of Ki-67 was transiently increased at 2 and 5 wk after surgery in the contralateral kidney of RAS animals and returned to control levels by 11 wk after surgery (Fig. 3, B and C). In the stenotic kidney, increased Ki-67 staining was observed at all time points, within tubular epithelial cells as well as interstitial cells (Fig. 3B) . Distribution of Ki-67 cells was heterogeneous, with clusters of positive cells apparently belonging to the same nephron unit interspersed with other nephron units that did not express Ki-67 (Fig. 3, B3, B5 , and B7). Protein-to-DNA ratios obtained from the contralateral kidneys of RAS and sham-operated control animals showed no significant differences, providing further support that the compensatory enlargement of the contralateral kidney occurs at least in part through hyperplasia (data not shown).
The temporal profile of expression of ERK differs in the stenotic and contralateral kidneys. Having established that compensatory enlargement of the contralateral kidney is due at least in part to hyperplasia, we asked whether changes in ERK signaling paralleled the changes in proliferative activity observed in RAS mice. As shown by Western blot analysis, increased p-ERK expression was observed in the contralateral kidney at 2 and 5 wk following 2K1C surgery, with a return to baseline levels at 11 wk. In the stenotic kidney, p-ERK expression was persistently elevated at all time points (Fig. 4) .
G 1 /S and G 2 /M phase cyclins are differentially expressed in the stenotic and contralateral kidneys. Progression of cells from the G 1 to S phase of the cell cycle is directed by activation of the cyclin-cyclin-dependent kinase (cdk) complexes cyclin D-cdk4, 6 and cyclin E-cdk2. Expression of cyclin D and cyclin E in the stenotic and contralateral kidneys at 2, 5, and 11 wk after surgery to establish renal artery stenosis was assessed by Western blot analysis. In the contralateral kidney, no signifi- Fig. 3 . Proliferative activity is markedly and persistently increased in the stenotic kidney and transiently increased in the contralateral kidney in RAS mice. A: Western blots were prepared from renal homogenates of control and RAS mice and probed with an antibody directed against the proliferation marker proliferating cell nuclear antigen (PCNA). Blots were stripped and reprobed with ERK2 as loading control. Images are blots of representative experiments. Sh, sham-operated kidneys; Co, contralateral kidneys; St, stenotic kidneys. Data are means Ϯ SE; n Ն 3. *P Ͻ 0.05 vs. Sh from control mice. ϩP Ͻ 0.05 vs. Co from RAS mice. #P Ͻ 0.05 vs. Co from control mice. B: histological sections obtained from kidneys of RAS and control mice were stained with the proliferation marker Ki-67. Images are representative sham-operated (1) and contralateral kidneys (2) from a control mouse 11 wk after surgery and representative stenotic (3, 5, 7) and contralateral kidneys (4, 6, 8) from RAS mice at 2, 5, and 11 wk, respectively, after surgery. C: Ki-67 staining was quantitated, relative to cortical surface area, using the MetaVue image analysis system. Data are means Ϯ SE; n Ն 3. *P Ͻ 0.05 vs. Sh from control mice. ϩP Ͻ 0.05 vs. Co from RAS mice. #P Ͻ 0.05 vs. Co from control mice. cant alterations in cyclin D1 expression were observed. However, renal atrophy in the stenotic kidney was associated with a decrease in cyclin D1 expression at 5 and 11 wk (Fig. 5A) . Expression of cyclin E was increased in both the stenotic and contralateral kidneys at 2 wk (Fig. 5B) . At 5 wk, cyclin E expression was increased in the contralateral kidney but decreased in the stenotic kidney. At 11 wk, after the contralateral kidney assumed its new steady-state size, cyclin E levels returned to baseline levels. Cyclin E levels remained decreased in the stenotic kidney at 11 wk (Fig. 5B) .
Progression of cells from the G 2 to M phase of the cell cycle occurs through activation of cyclins A-cdk2 and B-cdk1. Expression of cyclin A and cyclin B1 in the stenotic and contralateral kidneys at 2, 5, and 11 wk after surgery was assessed by Western blot analysis. Expression of cyclin A in the contralateral kidney was unchanged throughout 11 wk of observation, whereas expression of cyclin A was increased at 5 wk in the stenotic kidney, with return to baseline levels at 11 wk (Fig. 6A) . Compared with time-matched sham-operated controls, expression of cyclin B1 was increased in both the stenotic and contralateral kidneys at 5 wk but was unchanged at other time points (Fig. 6B) . Immunohistochemical studies were performed to localize cyclin A expression. Weak staining for cyclin A was observed in the majority of cortical and medullary tubular epithelial cells, with individual cells demonstrating stronger staining. Strongest staining was observed in both the stenotic and contralateral kidneys at 5 wk (data not shown).
Temporal induction of the cell cycle inhibitors p21 and p27 differs in the stenotic and contralateral kidneys. Progression of the cell cycle is interrupted by expression of cdk inhibitors, which bind and inactivate cyclin-cdk complexes (5, 23, 36) . The cell cycle inhibitors p21 and p27 play an important role in this process, because they are capable of binding and inactivating both G 1 /S and G 2 /M phase cyclin-cdk complexes. Expression of the cell cycle inhibitors p21 and p27 in the kidneys of RAS and sham-operated control mice was examined by Western blot analysis. Two weeks after induction of RAS, p27 expression was significantly increased in both the stenotic and contralateral kidneys. Levels of p27 in the contralateral kidney had returned to baseline at 5 wk, whereas in the stenotic kidney these levels progressively increased through 11 wk (Fig. 7) . Immunohistochemical studies were performed to identify cell type(s) expressing p27. At all time points, strongest expression of p27 was observed in glomerular visceral epithelial cells (podocytes). Focal expression of p27 was observed within tubules residing in the medulla and the renal cortex; distal tubules within the renal cortex expressed p27 more strongly than proximal tubules. p27 expression was transiently increased in the contralateral kidney and persistently elevated in the stenotic kidney (data not shown).
As shown by Western blot analysis, levels of p21 were unchanged in both kidneys 2 wk after surgery but increased in the stenotic kidney at 5 and 11 wk (Fig. 8) . In sham-operated controls, weak immunohistochemical staining for p21 was observed in both cortical and medullary tubular epithelial cells. In the stenotic kidney at 5 and 11 wk after surgery, an increased number of tubular epithelial cells strongly expressed p21 compared with the contralateral kidney and sham controls (data not shown).
Whereas compensatory hyperplasia of the contralateral kidney is associated with a transient increase in PCNA and Ki-67 expression and an early induction of p27, involution of the stenotic kidney is associated with a persistent increase in markers of both proliferation (PCNA, Ki-67) and cell cycle arrest (p21, p27). In the stenotic kidney, it is possible that different populations of cortical tubular epithelial cells express markers of proliferation and cell cycle arrest. Alternatively, it is possible that the same cell coexpresses markers of proliferation and inhibition, indicating a G 2 /M phase cell cycle arrest. Along those lines, p21 has been shown to bind PCNA, thereby inducing G 2 arrest (23, 38) . To exclude the latter possibility, we immunoprecipitated p21 from a renal homogenate and probed the Western blot for PCNA. No bands were identified. In a control experiment, we were able to detect a band when we immunoprecipitated with p21 and detected with cyclin B, verifying that we are able to detect p21 complexed to other proteins (data not shown). Review of slides stained for Ki-67 and p21 failed to demonstrate a clear pattern of colocalization (data not shown).
Although p53 is induced in the stenotic kidney, there is little evidence of apoptosis.
Since induction of cell cycle inhibitors by p53 may account for cell cycle arrest, we asked whether induction of p21 or p27 in the stenotic and contralateral kidneys of RAS mice was caused by upregulation of p53. In the stenotic kidney, p53 levels progressively increased with time after induction of RAS. In the contralateral kidney, significant induction of p53 was observed at 5 wk, but it returned to baseline at 11 wk (Fig. 9A) . Tissue hypoxia is one of the major mechanisms that activates p53, which subsequently induces apoptosis (7). Caspase-3 expression was examined to determine whether renal atrophy in the stenotic kidney of RAS mice was associated with increased apoptotic activity. Expression of caspase-3 was significantly increased in both the stenotic and contralateral kidneys 2 wk after surgery. Significant proliferative activity was also observed in both kid- neys at this time point (see above). Levels of caspase-3 returned to baseline by 5 wk in the stenotic kidney and by 11 wk in the contralateral kidney (Fig. 9B) . Similar findings were obtained when apoptosis was assessed in renal tissue from RAS and control mice by terminal deoxynucleotidyl transferase dUTP-mediated nick-end label (TUNEL) staining (data not shown).
TGF-␤1 is persistently induced in the stenotic kidney and transiently induced in the contralateral kidney. In addition to being a predominant mediator of chronic inflammation, extracellular matrix deposition, and tissue fibrosis, TGF-␤1 is a potent cell cycle regulator that acts at least in part through induction of p21 and/or p27 (2, 3, 19, 26) . Based on Northern blot analysis, TGF-␤1 was increased in both the stenotic and contralateral kidneys at 2 and 5 wk after induction of RAS (Fig. 10A) . TGF-␤1 mRNA in the contralateral kidney returned to baseline levels by 11 wk, the same time proliferative activity was observed to return to baseline. In the stenotic kidney, however, TGF-␤1 expression progressively increased through the 11-wk observation period (Fig. 10A) . Since Smad2 and Smad3 are downstream mediators of TGF-␤1, we sought to determine whether Smad2/3 expression is regulated in a similar fashion in RAS and control mice. Smad2/3 levels were increased persistently in the stenotic kidney throughout the entire experimental period, whereas in the contralateral kidney, Smad2/3 expression was increased only at 2 and 5 wk and returned to baseline levels at 11 wk (Fig. 10B) . This progressive increase in TGF-␤1 and Smad2/3 expression is attended by the development of interstitial fibrosis in the stenotic kidney (see below).
Development of tubular atrophy in the stenotic kidney is associated with increased collagen deposition and increased ␣-SMA expression. Although the stenotic kidney at 2 wk showed minimal histopathological alterations, quantitative analysis of Sirius red-stained sections observed under polarized light revealed a significant increase in fibrillar collagen deposition (Fig. 11A) . Collagen deposition in the contralateral kidney of RAS mice at this time point was not significantly different from that in the sham controls (Fig. 11A) . At 5 and 11 wk after surgery, progressive interstitial fibrillar collagen accumulation was observed in the stenotic but not the contralateral kidney (Fig. 11A) . The development of interstitial fibrosis in the kidney and other organs has been linked to epithelial to mesenchymal transformation of tubular cells. ␣-SMA has been used as a marker for this process. In both kidneys of shamoperated control mice and in the contralateral kidney of RAS mice, ␣-SMA staining was almost exclusively limited to interstitial arteries and arterioles; minimal interstitial or peritubular staining was observed (data not shown). In the stenotic kidney, the percentage of cortical surface area staining positively for ␣-SMA was similar to that for controls at 2 and 5 wk but increased significantly by 11 wk after surgery (Fig. 11B) .
Development of interstitial fibrosis and tubular atrophy in the stenotic kidney is associated with progressive inflammation. We and others have demonstrated that MCP-1 is a predominant mediator of inflammation in many forms of acute and chronic renal disease. Induction of MCP-1 mRNA was observed in the stenotic but not the contralateral kidney 2 wk after RAS. MCP-1 expression was persistently elevated after 11 wk in the stenotic but not the contralateral kidney (Fig. 12) . Fig. 10 . Transforming growth factor (TGF)-␤1 and Smad2/3 are persistently induced in the stenotic kidney but only transiently induced in the contralateral kidney. A: 2, 5, and 11 wk after surgery, total RNA was isolated from kidneys of control and RAS mice using the Trizol method. Northern blots were prepared and probed for TGF-␤1. Blots were then stripped and reprobed for GAPDH as loading control. B: Western blots of renal homogenates from control and RAS mice were probed with a Smad2/3 antibody and then stripped and reprobed with ERK2 as loading control. Images are blots of representative experiments. Data are means Ϯ SE; n Ն 3. *P Ͻ 0.05 vs. Sh from control mice. ϩP Ͻ 0.05 vs. Co from RAS mice. #P Ͻ 0.05 vs. Co from control mice.
DISCUSSION
Unlike the rat model of 2K1C, which is long established and thoroughly characterized, the murine 2K1C model was introduced relatively recently and remains poorly characterized in many of its essential features (18, 39) . The unique advantage of the murine model of the 2K1C model is that it enables the use of genetically altered mice such that the pathogenetic significance and contribution of specific molecular species can be evaluated. However, a fundamental and necessary prerequisite for such studies is a clear delineation of the expression of genes/proteins relevant to biological changes in the stenotic and contralateral kidney in the 2K1C model and the manner in which such gene/protein expression and the phenotype of either kidney are temporally and progressively altered in this disease model. It is this essential issue that the present studies address.
A salient characteristic of the 2K1C model is the pronounced divergence of growth responses observed in the two kidneys: the stenotic kidney undergoes atrophy and fibrosis, whereas the contralateral kidney exhibits an exuberant growth response. To the best of our knowledge, our study is the first to simultaneously analyze the temporal changes observed in the atrophying stenotic kidney and enlarging contralateral kidney by delineating alterations in genes/proteins critical to relevant biological processes, including those involved in cell proliferation (PCNA, Ki-67, ERK), cell cycle (cyclins D, E, A, and B; p21; p27), cell hypertrophy (p21, p27, TGF-␤1), inflammation (MCP-1), cell survival and apoptosis (p-ERK, p53, caspase), epithelial-mesenchymal transformation (␣-SMA), and fibrosis (TGF-␤1; Smad2 and 3). Such information, summarized in Tables 2 and 3 , provides a basic framework in elucidating the divergent responses observed in the two kidneys in this model, as well as a basis for subsequent studies employing genetically altered mice lacking a specific gene or protein.
In addition to documenting the expected changes in size and histology in the stenotic and contralateral kidneys, our study provides information that is currently unavailable in the literature (Tables 2 and 3 ). First, our study addresses the basis for the compensatory enlargement of the contralateral kidney in the 2K1C model. Enlargement of the contralateral kidney was associated with transient increases in PCNA expression and immunohistochemical staining for Ki-67. The protein-to-DNA ratios of the contralateral kidney of RAS mice were maintained compared with the contralateral kidney of sham-operated control animals. These studies indicate that the compensatory enlargement of the contralateral kidney occurs at least in part due to hyperplasia. In a unilateral nephrectomy model in both rats and C57BL/6 mice, compensatory renal enlargement is primarily mediated by a cell cycle-dependent hypertrophy, not hyperplasia (21, 27) . However, subtotal but not unilateral nephrectomy induces a hyperplastic response (32) . Based on these considerations, the adaptive response of the contralateral kidney in our murine 2K1C model resembles subtotal rather than unilateral nephrectomy. Second, despite the progressive atrophy of the stenotic kidney in the murine 2K1C model, the stenotic kidney, quite surprisingly, showed a robust increase in markers of cell proliferation and continued cell cycle activity; such activity was observed predominantly within renal cortical tubular epithelial cells. The demonstration of a proliferative response in the stenotic, atrophic kidney in the 2K1C model was unexpected and, to the best of our knowledge, has not been described previously in either clinical or experimental RAS. We observed that clusters, or groups, of tubular epithelial cells expressed markers of proliferation and were surrounded by groups of cells that did not express markers of proliferation. Atrophy was associated with reduced levels of G 1 /S phase cyclins (cyclin D, cyclin E) but a transient increase in expression of G 2 /M phase cyclins (cyclin A, cyclin B). Although it is well recognized in the field of progressive kidney disease that increased cell proliferation can culminate in injury and atrophy, the finding that an atrophying kidney concomitantly exhibits a proliferative response is an unusual and unexpected finding in injured tissues and organs. Third, despite the progressive and marked atrophy of the stenotic kidney, the stenotic kidney showed unimpressive evidence of apoptotic cell death. In aggregate, these observations thus challenge the currently accepted paradigm of renal atrophy as a process characterized by widespread apoptosis with decreased proliferative activity. Fourth, our studies provide the first demonstration in the stenotic kidney in the murine 2K1C model of the occurrence of epithelial-mesenchymal transition, the latter considered a pathophysiological alteration that contributes to chronic kidney disease.
To explore the molecular basis for the phenotypic features of the stenotic and contralateral kidney, we examined cellular pathways relevant to these features. Because of the marked increase in proliferative activity, expression of ERK was assessed, and such expression of ERK in the stenotic and contralateral kidneys exactly mirrored the changes in proliferative markers observed in these kidneys. There is substantial evidence in both clinical nephritides and disease models linking increased ERK activity with cell proliferation in the glomerular and tubular compartments and increased ERK expression in regions of glomerular and interstitial damage (25) . In view of these considerations, we suggest that the temporal changes in ERK expression may contribute, at least in part, to the proliferative profile observed in the stenotic and contralateral kidneys.
We also suggest that changes in expression of ERK may contribute not only to the proliferative changes but also to chronic injury observed in the stenotic kidney. This suggestion is based on the following considerations. First, as is well established in the field of progressive kidney injury, a sustained increase in cellular proliferative response, via a number of mechanisms, can herald and culminate in chronic injury. Second, the temporal profile of ERK expression in the stenotic and contralateral kidney exactly recapitulated that exhibited by TGF-␤1 (Table 3) , a cytokine of fundamental significance in epithelial-mesenchymal transition and production of extracellular matrix; relevant to these considerations are the facts that upregulation of ERK can induce epithelial-mesenchymal transition (20, 40, 41) and that ERK is essential for TGF-␤1- induced production of extracellular matrix (11) . In this regard, it is notable that the upregulation of ERK was sustained in the stenotic kidney, whereas in the contralateral kidney, ERK returned to baseline level of expression in the later phases of the 2K1C model. Indeed, sustained induction of ERK may be responsible for the increased numbers of tubular epithelial cells expressing markers of proliferation despite increased levels of TGF-␤, which is an inhibitor of tubular epithelial cell proliferation. Sustained upregulation of ERK can contribute to chronic injury as demonstrated by studies employing pharmacological inhibition of ERK (1, 16) . On the basis of these considerations, we suggest that the transient induction of ERK in the contralateral kidney is likely responsible for the compensatory hyperplastic response to unilateral RAS in the 2K1C model, whereas persistent induction of ERK in the stenotic kidney may promote the development of interstitial fibrosis and tubular atrophy. The persistent upregulation of ERK and TGF-␤1 in the stenotic kidney was accompanied by increased expression of MCP-1, a potent proinflammatory chemokine that was unaltered in expression in the contralateral kidney. In view of this temporal profile of MCP-1 expression and the presence of interstitial inflammation in the stenotic but not the contralateral kidney, it seems likely that MCP-1 contributes to the interstitial inflammation observed in the stenotic kidney.
We explored the basis for atrophy of the stenotic kidney by assessing apoptosis and relevant proteins. p53, a protein widely recognized for its cytoreductive effects, was quite strongly upregulated in the stenotic kidney at all phases, a finding not observed in the contralateral kidney; we suggest that such upregulation of p53 may contribute to the atrophy of the stenotic kidney. It is notable that cell death, as assessed by TUNEL staining and by increased expression of caspase-3, a proapoptotic protein common to both the intrinsic and extrinsic apoptotic pathways, was observed only at an early time point in the stenotic kidney. The disparity between cell death, as assessed by these indexes, and the expression of p53 is quite surprising and may reflect the following considerations. First, as is generally well accepted, histological assessment of apoptosis as provided by such approaches as TUNEL staining may underrepresent the occurrence of apoptosis in tissues. Second, cells undergoing apoptosis may be readily sloughed into the urinary space and are thereby not "captured" on TUNEL staining. Third, the marked and sustained increase in p53 in the stenotic kidney was exactly paralleled by the expression of p27 and, to a considerable extent, by expression of p21. P27 exerts prosurvival properties. For example, kidney cells derived from p27 knockout mice have strikingly elevated rates of apoptosis when deprived of growth factors (13) . In models of glomerular and tubulointerstitial disease, a prosurvival effect of p27 has been demonstrated (13, 31) . p21 is also capable of protecting cells from apoptosis (12, 15) . We speculate that the lack of prominence of apoptosis despite marked upregulation of the cytoreductive protein p53 may reflect the countervailing influence of the prosurvival proteins p27 and/or p21.
In summary, our present studies provide a sequential and temporal characterization of biological processes of atrophy and growth that envelope, respectively, the ipsilateral stenotic and contralateral intact kidney in the 2K1C model; the temporal profiles observed for key participants in chronic kidney disease in these two kidneys are quite distinct. We suggest that temporal profiles identified for key participants in chronic kidney disease and the manner in which they correlate with these biological processes of atrophy and growth provide a basis for subsequent studies wherein the precise role for these participants can be delineated by employing genetically altered mutant mice and other approaches.
